Propecia Lawsuits: Next Status Conference in New Jersey Propecia...
The Firm is currently evaluating Propecia lawsuits on behalf of men who suffered persistent sexual dysfunction allegedly due to Propecia.(PRWeb February 17, 2013)Read the full story at http://www.prweb.com/releases/propecia-lawsuits/propecia-side-effects/prweb10437928.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 17, 2013 Category: Pharmaceuticals Source Type: news
Proscar Won’t Boost Prostate Cancer Survival, Study Finds
Drug does appear to reduce diagnosis of the disease, researchers say (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 15, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Oncology, Pharmacy, Reproductive Medicine, Urology, News, Source Type: news
Dr. Reddy's Laboratories Launches Generic Form of Propecia to...
Dr. Reddy's Laboratories Ltd. announced recently that it has started selling the generic form of the anti-hair loss drug Propecia. According to a Jan. 3 news report in Fox News, sale of...(PRWeb February 02, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10389762.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 4, 2013 Category: Pharmaceuticals Source Type: news
New Generic Propecia Launched: Now, AttorneyOne Can Provide Advice for...
On January 2nd 2013, Dr. Reddy’s announced the launch of Finasteride Tablets (1 mg), a bioequivalent generic version of Propecia Tablets in the US market. In light of these news, AttorneyOne, a...(PRWeb January 23, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10349586.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 23, 2013 Category: Pharmaceuticals Source Type: news
Going bald by 40 'raises prostate cancer risk'
Conclusion
This well designed trial indicates that the relationship between male pattern baldness and incidence of prostate cancer varies depending on age. Up to the age of 76 years, those showing signs of baldness at 40 are generally at higher risk, but this is not the case at older ages. The risk of having prostate cancer in men over 76 years old was around 15%, regardless of hair loss at 40.
This trial had many strengths, including its design and large sample size. However, the following limitations should be considered when interpreting the results of the study:
The study did not test any biological mechanism exp...
Source: NHS News Feed - January 23, 2013 Category: Consumer Health News Tags: Cancer Source Type: news
